| Literature DB >> 25240660 |
Robert Bolash1, Nagy Mekhail2.
Abstract
Intrathecal drug delivery represents an advanced modality for refractory chronic pain patients as well as intractable spasticity. This article reviews the advantages and indications for intrathecal therapy, as well as recommendations for proper patient selection using a multidisciplinary team to provide a global assessment of the impact of chronic pain on the patient's well-being. The goals and expectations of trialing are discussed alongside advantages and disadvantages of several trialing techniques. A discussion of outcomes is presented for patients with chronic pain due to both malignant and nonmalignant causes.Entities:
Keywords: Chronic pain; Intractable spasticity; Intrathecal drug delivery; Intrathecal pain pumps
Mesh:
Substances:
Year: 2014 PMID: 25240660 DOI: 10.1016/j.nec.2014.06.006
Source DB: PubMed Journal: Neurosurg Clin N Am ISSN: 1042-3680 Impact factor: 2.509